Last month, our team had the pleasure of attending the European Network to Cure ALS (ENCALS) meeting, an annual gathering that brings together some of the brigh...
Continue reading
£330K grant awarded to support and engage patients at risk of MND/ALS, and track the psychological impact of genetic testing.
Continue reading
This webinar, hosted by Paul Wicks and featuring a panel of experts in ALS and genetics, focuses on the challenges and variability in genetic testing and counse...
Continue reading
Mutations in the SOD1 gene were the first identified genetic cause of ALS, discovered in 1993. Yet SOD1-ALS accounts for only approximately 2% of all ALS cases,...
Continue reading
This webinar, moderated by Patrick Short, CEO and co-founder of Sano Genetics, and featuring two panelists, Jessi Keavney and Krista Qualmann, discussed the imp...
Continue reading
Parkinson's disease (PD) is a complex neurodegenerative disorder driven by a combination of genetic and environmental factors. While most cases cannot be attrib...
Continue reading
Clinical trials play a critical role in developing new treatments and therapies for Parkinson's disease, an age-related degenerative brain condition that causes...
Continue reading
This webinar, hosted by Patrick Short, CEO of Sano Genetics, and featuring Dr. Mark Kotter, CEO of bit.bio, focused on precision medicine in multiple sclerosis....
Continue reading
If you missed our webinar, you can catch up on an exciting discussion about the future of precision medicine research in multiple sclerosis here on our blog.
Continue reading